About Us

AIM is a software engineering firm, in operation since 1983, specializing in the design, development and support of information systems for the healthcare industry, with a focus on cancer control. Clients include cancer agencies in Canada and the USA, hospitals, commercial medical laboratories and research facilities.

AIM has developed a number of comprehensive applications: ISIS, a suite of cancer informatics products for preventive oncology, automated data collection and cancer registries; TransMed for electronic data interchange; AutoCode for text processing and automated coding; and TissueMetrix an integrated database/application system that lets you build and maintain comprehensive biospecimen repositories.

For more information, please download our Corporate Brochure.

News and Events

01-Oct-2008 - Press Release: National Cancer Institute of the United States Expands Use of AIM's E-Path Software
The Surveillance, Epidemiology, and End Results (SEER) Program of the National Cancer Institute (NCI) and Artificial Intelligence in Medicine Inc. (AIM) are pleased to announce a five year extension of their original 2003 agreement... To read the whole release click here

06-June-2008 - Read the new E-Path Site News
The announcement that Senator Edward Kennedy has been diagnosed with a glioma has raised public awareness of the devastating effects of many CNS neoplasms. Find out more... click here

• NAACCR - North American Association of Cancer Registries.
• NCRA - National Cancer Registrars Association
• ISBER - International Society for Biologic and Environmental Repositories
• HIMSS - Healthcare Information and Management Systems Society

• LRIG - Laboratory Robotics Interest Group
• Oracle Partner Network
• HL7 - Health Level Seven. HL7 is accredited by the American National Standards Institute (ANSI) to produce standards, specifications and protocols for clinical and administrative data in healthcare.